These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26434871)

  • 1. Epidemiological Study of Laryngeal Carcinoma in Western Nepal.
    Koirala K
    Asian Pac J Cancer Prev; 2015; 16(15):6541-4. PubMed ID: 26434871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supraglottic and glottic carcinomas. Study of the incidence in the last 31 years].
    Tamarit Conejeros JM; Carrasco Llatas M; Estellés Ferriol E; Fernández Martínez S; Baviera Granell N; Dalmau Galofre J
    Acta Otorrinolaringol Esp; 2007 Dec; 58(10):449-53. PubMed ID: 18082073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinico-Epidemiologic Patterns of Laryngeal Cancer: 5-year Results from a Regional Cancer Centre in Northeastern India.
    Nallathambi C; Yumkhaibam SD; Singh LJ; Singh TT; Singh IY; Daniel N
    Asian Pac J Cancer Prev; 2016; 17(5):2439-43. PubMed ID: 27268611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe.
    Hashibe M; Boffetta P; Zaridze D; Shangina O; Szeszenia-Dabrowska N; Mates D; Fabiánová E; Rudnai P; Brennan P
    Am J Epidemiol; 2007 Apr; 165(7):814-20. PubMed ID: 17244634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender influences subsite of origin of laryngeal carcinoma.
    Stephenson WT; Barnes DE; Holmes FF; Norris CW
    Arch Otolaryngol Head Neck Surg; 1991 Jul; 117(7):774-8. PubMed ID: 1863444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco, alcohol use, and risks of laryngeal and lung cancer by subsite and histologic type in Turkey.
    Dosemeci M; Gokmen I; Unsal M; Hayes RB; Blair A
    Cancer Causes Control; 1997 Sep; 8(5):729-37. PubMed ID: 9328195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the sex ratio of laryngeal cancer incidence rates by anatomic subsite.
    Yang PC; Thomas DB; Daling JR; Davis S
    J Clin Epidemiol; 1989; 42(8):755-8. PubMed ID: 2788212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supraglottic and glottic carcinomas: epidemiologically distinct entities?
    De Stefani E; Boffetta P; Deneo-Pellegrini H; Brennan P; Correa P; Oreggia F; Ronco AL; Mendilaharsu M
    Int J Cancer; 2004 Dec; 112(6):1065-71. PubMed ID: 15386361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
    Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
    PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress against laryngeal cancer in The Netherlands between 1989 and 2010.
    van Dijk BA; Karim-Kos HE; Coebergh JW; Marres HA; de Vries E
    Int J Cancer; 2014 Feb; 134(3):674-81. PubMed ID: 23873096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV infection and clinical profiles in laryngeal diseases. A preliminary study.
    Giacomini PG; Di Mauro R; Martino F; Passali FM; Crolla C; Di Girolamo S
    Ann Ital Chir; 2019; 90():398-403. PubMed ID: 31814599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the subsite distribution of laryngeal cancer related to smoking habits?
    Virtaniemi JA; Hirvikoski PP; Kumpulainen EJ; Johansson RT; Pukkala E; Kosma VM
    Acta Oncol; 2000; 39(1):77-9. PubMed ID: 10752658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of laryngeal cancer.
    Krajina Z; Kulcar Z; Konić-Carnelutti V
    Laryngoscope; 1975 Jul; 85(7):1155-61. PubMed ID: 1152564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Larynx cancer in Slovakia and the role of anatomical subsites.
    Severi G; Plesko I; Robertson C; Obsitnikova A; Boyle P
    Oral Oncol; 1999 Nov; 35(6):564-70. PubMed ID: 10705091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer of the larynx: the northern Alberta experience.
    Marck PA; Lupin AJ
    J Otolaryngol; 1989 Dec; 18(7):344-9. PubMed ID: 2593218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis.
    Yücetürk AV; Celik O; Eskiizmir G
    Kulak Burun Bogaz Ihtis Derg; 2003 Nov; 11(5):129-33. PubMed ID: 15542939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous opioid drug abuse as an independent risk factor for supraglottic squamous cell carcinoma-A case-control study.
    Shoffel-Havakuk H; Cohen O; Slavin M; Haimovich Y; Halperin D; Lahav Y
    Clin Otolaryngol; 2018 Apr; 43(2):456-462. PubMed ID: 28950046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglottic cancer of the larynx--a case presentation.
    Medonca DR; Bryce DP
    Can J Otolaryngol; 1973; 2(3):271-6. PubMed ID: 4791589
    [No Abstract]   [Full Text] [Related]  

  • 19. Dysplastic Changes in Patients with Recurrent Laryngeal Leukoplakia: Importance of Long-Term Follow-Up.
    Jabarin B; Pitaro J; Marom T; Muallem-Kalmovich L
    Isr Med Assoc J; 2018 Oct; 20(10):623-626. PubMed ID: 30324779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laterality of laryngeal cancer.
    Virtaniemi JA; Hirvikoski PP; Kumpulainen EJ; Johansson RT; Kosma VM
    Acta Oncol; 1999; 38(5):666. PubMed ID: 10427960
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.